The overall clinical efficacy of Zaynich across indications was 98% at the test-of-cure
The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective
The product is manufactured at AKUMS’ state-of-the-art injectable facility in Kotdwar, Uttarakhand
Collaboration integrates SmartChip PCR technology with cloud-based analytics to enable faster, standardised monitoring of antimicrobial resistance
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations
The new assay consolidates screening for four major viral threats into a single workflow
The approval means US laboratories can now run both respiratory and gastrointestinal panels on the high-throughput QIAstat-Dx Rise
The VELO system supports multiplex testing for Influenza A, Influenza B, and COVID-19, producing PCR results in six to ten minutes
Subscribe To Our Newsletter & Stay Updated
